Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Painless Fiberoptic Bronchoscopy
ChiCTR2500108395Phase 4Not yet recruiting
- Sponsor
- Qingdao Municipal Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in pulmonary diseases (2 arms), sponsored by Qingdao Municipal Hospital. Primary endpoint: Incidence of coughing response. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
pulmonary diseases
Beyond the preview
Go deeper on ChiCTR2500108395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108395.